Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ADC Therapeutics SA | Director | Common Shares | 80.7K | $233K | $2.89 | Jun 17, 2024 | Direct |
Travere Therapeutics, Inc. | Director | Common Stock | 28.9K | $195K | $6.74 | May 8, 2024 | Direct |
Deciphera Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | $0 | $10.58 | Jun 11, 2024 | Direct |
Travere Therapeutics, Inc. | Director | Stock option (right to buy) | 19.5K | May 8, 2024 | Direct |